Home/Filings/4/0001209191-17-009821
4//SEC Filing

BioAmber Inc. 4

Accession 0001209191-17-009821

CIK 0001534287operating

Filed

Feb 12, 7:00 PM ET

Accepted

Feb 13, 7:29 AM ET

Size

7.7 KB

Accession

0001209191-17-009821

Insider Transaction Report

Form 4
Period: 2017-02-09
Orecchioni Fabrice
Chief Operations Officer
Transactions
  • Award

    Stock-Option (right to buy)

    2017-02-09+51,35151,351 total
    Exercise: $3.55Exp: 2022-02-08Common shares (51,351 underlying)
  • Award

    Stock-Option (right to buy)

    2017-02-09+80,00080,000 total
    Exercise: $3.55Exp: 2027-02-08Common shares (80,000 underlying)
Footnotes (2)
  • [F1]vesting monthly over one (1) year from the grant date.
  • [F2]Vesting as follows: twenty-five percent (25%) vesting at the first anniversary date following the grant date, and the remaining seventy-five percent (75%) vesting on a monthly basis over the three (3) following years.

Issuer

BioAmber Inc.

CIK 0001534287

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001534287

Filing Metadata

Form type
4
Filed
Feb 12, 7:00 PM ET
Accepted
Feb 13, 7:29 AM ET
Size
7.7 KB